SCHEMBL7647330

SCHEMBL7647330

CCC(CCO)c1ccc(-c2cc(OCc3ccc(CO)c(CO)c3)ccc2C)c(C(C)(C)C)c1

nearest known ligand 0.44

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 16/20 0.44
VDR P11473 4/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7607761 0.90 VDR (0.45) FFAR1VDR
SCHEMBL7607682 0.89 VDR (0.44) FFAR1VDR
SCHEMBL7610926 0.86 VDR (0.42) FFAR1VDR
SCHEMBL7605149 0.85 FFAR1 (0.53) FFAR1VDR
SCHEMBL7606174 0.83 VDR (0.53) FFAR1VDR
SCHEMBL7611575 0.83 VDR (0.41) FFAR1VDR
SCHEMBL7610503 0.82 VDR (0.42) FFAR1VDR
SCHEMBL6566261 0.79 VDR (0.63) FFAR1VDR
SCHEMBL7610502 0.79 VDR (0.42) FFAR1VDR
SCHEMBL7606369 0.77 FFAR1 (0.43) FFAR1VDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1235777-A2 VITAMIN D ANALOGUES Galderma Research & Development, S.N.C. (FR) 2002-09-04 EP claimed
WO-2001038303-A2 VITAMIN D ANALOGUES GALDERMA RESEARCH & DEVELOPMENT, S.N.C. (FR) 2001-05-31 WO claimed
EP-1235777-A2 VITAMIN D ANALOGUES Galderma Research & Development, S.N.C. (FR) 2002-09-04 EP disclosed
WO-2001038303-A2 VITAMIN D ANALOGUES GALDERMA RESEARCH & DEVELOPMENT, S.N.C. (FR) 2001-05-31 WO disclosed